Effects of combining zibotentan and dapagliflozins on chronic kidney disease: an innovative frontier

Int Urol Nephrol. 2024 Dec 4. doi: 10.1007/s11255-024-04310-3. Online ahead of print.
No abstract available

Publication types

  • Letter